Coverage of "Skyrizi" on Cryptopasta: the stories and the context behind them.
Humira’s fall leaves a massive revenue gap. AbbVie bets on Skyrizi and Rinvoq to grow fast enough across diseases and markets to offset biosimilar competition.
July 31, 2026
